REFERENCES
- Anel-LopezL, Alvarez-RodriguezM, Garcia-AlvarezO, AlvarezM, Maroto-MoralesA, AnelL, de PazP, GardeJJ, Martinez-PastorF. Reduced glutathione and Trolox (vitamin E) as extender supplements in cryopreservation of red deer epididymal spermatozoa. Anim Reprod Sci. 2012;135:37–46.
- LjubisavljevicS, StojanovicI, PavlovicR, StojnevS, StevanovicI, SokolovicD, PavlovicD. The reduced glutathione and S-nitrosothiols levels in acute phase of experimental demyelination – pathophysiological approach and possible clinical relevancy. Neuroscience. 2012;219:175–182.
- SzaromaW, DziubekK. Changes in the amount of reduced glutathione and activity of antioxidant enzymes in chosen mouse organs influenced by zymosan and melatonin administration. Acta Biol Hung. 2011;62:133–141.
- AzfarSF, IslamN. Suppression of mycobacterium tuberculosis induced reactive oxygen species and tumor necrosis factor-alpha activity in human monocytes of systemic lupus erythematosus patients by reduced glutathione. Oman Med J. 2012;27:11–19.
- PicaudT, DesboisA. Interaction of glutathione reductase with heavy metal: the binding of Hg(II) or Cd(II) to the reduced enzyme affects both the redox dithiol pair and the flavin. Biochemistry. 2006;45:15829–15837.
- JoyS, NairPS, HariharanR, PillaiMR. Detailed comparison of the protein-ligand docking efficiencies of GOLD, a commercial package and ArgusLab, a licensable freeware. In Silico Biol. 2006;6:601–605.
- Van Der SpoelD, LindahlE, HessB, GroenhofG, MarkAE, BerendsenHJ. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26:1701–1718.
- HeJ, XuL, ZhangS, GuanJ, ShenM, LiH, SongY. Steered molecular dynamics simulation of the binding of the beta2 and beta3 regions in domain-swapped human cystatin C dimer. J Mol Model. 2013;19(2):825–832.
- ZhangY, LouJ. The Ca(2+) influence on calmodulin unfolding pathway: a steered molecular dynamics simulation study. PLoS ONE. 2012;7:e49013.
- VijayarajR, Van DammeS, BultinckP, SubramanianV. Molecular dynamics and umbrella sampling study of stabilizing factors in cyclic peptide-based nanotubes. J Phys Chem B. 2012;116:9922–9933.
- StockerU, van GunsterenWF. Molecular dynamics simulation of hen egg white lysozyme: a test of the GROMOS96 force field against nuclear magnetic resonance data. Proteins. 2000;40:145–153.
- PriceDJ, BrooksCL. A modified TIP3P water potential for simulation with Ewald summation. J Chem Phys. 2004;121:10096–10103.
- HessB, van Der SpoelD, LindahlE. Treatment of Cut-offs, Gromacs user manual version 4.5.4. University of Groningen; 2010.
- AbrahamMJ, GreadyJE. Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4.5. J Comput Chem. 2011;32:2031–2040.
- AndersonJS, LeMasterDM. Rotational velocity rescaling of molecular dynamics trajectories for direct prediction of protein NMR relaxation. Biophys Chem. 2012;168–169:28–39.
- SinghDV, AgarwalS, KesharwaniRK, MisraK. Molecular modeling and computational simulation of the photosystem-II reaction center to address isoproturon resistance in Phalaris minor. J Mol Model. 2012;18:3903–3913.
- HessB, BekkerH, BerendsenHJC, FraaijeJGEM. LINCS: a linear constraint solver for molecular simulations. J Comput Chem. 1997;18:1463–1472.
- Shirts RB, Burt SR, Johnson AM. Agreement with the Maxwell–Boltzmann distribution can be a flawed diagnostic for both accuracy and temperature in molecular dynamics simulations. Abstracts of Papers of the American Chemical Society. The 233rd ACS National Meeting; 2007 Mar 25–29; Chicago, IL ; 2007.
- MengF, XuW. Drug permeability prediction using PMF method. J Mol Model. 2013;19(3):991–997.
- ParkS, SchultenK. Calculating potentials of mean force from steered molecular dynamics simulations. J Chem Phys. 2004;120:5946–5961.
- ZhuF, HummerG. Convergence and error estimation in free energy calculations using the weighted histogram analysis method. J Comput Chem. 2012;33:453–465.
- DuncanMR, WangPL, MoldenhauerJE. Determining the capability of a drug product to be terminally sterilised: a case study involving a heat-sensitive, oxygen-sensitive drug product. Pharm Dev Technol. 1998;3:527–534.